MAPK1 and breast carcinoma: Through bioinformatics and microarray technology, Si et al. found that MAPK1 is involved in the chemotherapy tolerance of breast carcinoma, providing new paths for mechanism research and targeted therapy of chemotherapy tolerance (32).